Corrigendum to "Cell death and cytotoxic effects in YAC-1 lymphoma cells following exposure to various forms of mercury" [Toxicology 231 (2007) 40-57] (DOI:10.1016/j.tox.2006.11.062);Cell death and cytotoxic effects in YAC-1 lymphoma cells following exposure to various forms of mercury

Toxicology

Volumn 231, Issue 1, 2007, Pages 40-57

  Yole, Margaret ^a   Wickstrom, Mark ^a   Blakley, Barry ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cytotoxicity; Mercuric chloride; Methyl mercuric chloride; p Chloromercuribenzoate; Thimerosal; YAC 1 lymphoma

Indexed keywords

4 CHLOROMERCURIBENZOIC ACID; ACTIN; BETA TUBULIN; CALCIUM; CD3 ANTIGEN; DYE; ETHYLMERCURITHIOSALICYLIC ACID; F ACTIN; LYMPHOCYTE ANTIGEN RECEPTOR; MERCURIC CHLORIDE; MERCURY; METHYLMERCURIC CHLORIDE; PROPIDIUM IODIDE; PROTEIN TYROSINE KINASE; THIOMERSAL; TUBULIN; UNCLASSIFIED DRUG; YOPRO 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXICITY; DEPOLYMERIZATION; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; LYMPHOMA CELL; MICROTUBULE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN SYNTHESIS; TOXICITY TESTING;

EID: 33846826962     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.08.091     Document Type: Erratum

References (74)

1. Abal M., Andreu J.M., and Barasoain I. Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action. Curr. Cancer Drug Targets 3 (2003) 193-203
2. Alexandre H., Delsinne V., Goval J.J., and Van Cauwenberge A. Effect of taxol and okadaic acid on microtubule dynamics in thimerosal-arrested primary mouse oocytes: a confocal study. Biol. Cell. 95 (2003) 407-414
3. al-Sabti K. Micronuclei induced by selenium, mercury, methylmercury and their mixtures in binucleated blocked fish erythrocyte cells. Mutat. Res. 320 (1994) 157-163
4. Bachmann M.F., Oxenius A., Speiser D.E., Mariathasan S., Hengartner H., Zinkernagel R.M., and Ohashi P.S. Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 27 (1997) 2195-2203
5. Badou A., Savignac M., Moreau M., Leclerc C., Pasquier R., Druet P., and Pelletier L. HgCl2-induced interleukin-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels. J. Biol. Chem. 272 (1997) 32411-32418
6. Blakley B.R. Enhancement of urethan-induced adenoma formation in Swiss mice exposed to methylmercury. Can. J. Comp. Med. 48 (1984) 299-302
7. Blakley B.R., Sisodia C.S., and Mukkur T.K. The effect of methylmercury, tetraethyl lead, and sodium arsenite on the humoral immune response in mice. Toxicol. Appl. Pharmacol. 52 (1980) 245-254
8. Brown D.L., Reuhl K.R., Bormann S., and Little J.E. Effects of methyl mercury on the microtubule system of mouse lymphocytes. Toxicol. Appl. Pharm. 94 (1988) 66-75
9. Buttgereit F., Burmester G.R., and Brand M.D. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21 (2000) 192-199
10. Cai F., Backman H.A., and Baines M.G. Thimerosal: an ophthalmic preservative which acts as a hapten to elicit specific antibodies and cell mediated immunity. Curr. Eye Res. 7 (1988) 341-351
11. Cantrell D.A., Davies A.A., and Crumpton M.J. Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 8158-8162
12. Carranza-Rosales P., Said-Fernandez S., Sepulveda-Saavedra J., Cruz-Vega D.E., and Gandolfi A.J. Morphologic and functional alterations induced by low doses of mercuric chloride in the kidney OK cell line: ultrastructural evidence for an apoptotic mechanism of damage. Toxicology 210 (2005) 111-121
13. Castoldi A.F., Barni S., Turin I., Gandini C., and Manzo L. Early acute necrosis, delayed apoptosis and cytoskeletal breakdown in cultured cerebellar granule neurons exposed to methylmercury. J. Neurosci. Res. 59 (2000) 775-787
14. Colombo M., Hamelin C., Kouassi E., Fournier M., and Bernier J. Differential effects of mercury, lead, and cadmium on IL-2 production by Jurkat T cells. Clin. Immunol. 111 (2004) 311-322
15. Cooper J.A. Effects of cytochalasin and phalloidin on actin. J. Cell. Biol. 105 (1987) 1473-1478
16. Das V., Nal B., Dujeancourt A., Thoulouze M.I., Galli T., Roux P., Dautry-Varsat A., and Alcover A. Activation-induced polarized recycling targets T cell antigen receptors to the immunological synapse; involvement of SNARE complexes. Immunity 20 (2004) 577-588
17. Dietrich J., Menne C., Lauritsen J.P., von Essen M., Rasmussen A.B., Odum N., and Geisler C. Ligand-induced TCR down-regulation is not dependent on constitutive TCR cycling. J. Immunol. 168 (2002) 5434-5440
18. D'Oro U., Vacchio M.S., Weissman A.M., and Ashwell J.D. Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation. Immunity 7 (1997) 619-628
19. 2 in the Brown Norway rat. Ann. D Immunol. 129C (1978) 777-792
20. Far D.F., Peyron J.F., Imbert V., and Rossi B. Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry. Cytometry 15 (1994) 327-334
21. Foulkes E.C. Transport of toxic heavy metals across cell membranes. Proc. Soc. Exp. Biol. Med. 223 (2000) 234-240
22. Gremm D., and Wegner A. Gelsolin as a calcium-regulated actin filament-capping protein. Eur. J. Biochem. 267 (2000) 4339-4345
23. 2+ and membrane potential of thymocytes. Biochim. Biophys. Acta 1111 (1992) 65-74
24. Howard T.H., and Meyer W.H. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J. Cell Biol. 98 (1984) 1265-1271
25. Hultman P., and Enestrom S. Dose-response studies in murine mercury-induced autoimmunity and immune-complex disease. Toxicol. Appl. Pharmacol. 113 (1992) 199-208
26. Idziorek T., Estaquier J., De Bels F., and Ameisen J.C. YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J. Immunol. Methods 185 (1995) 249-258
27. Imura N., Miura K., Inokawa M., and Nakada S. Mechanism of methylmercury cytotoxicity: by biochemical and morphological experiments using cultured cells. Toxicology 17 (1980) 241-254
28. InSug O., Datar S., Koch C.J., Shapiro I.M., and Shenker B.J. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology 124 (1997) 211-224
29. 2 on murine lymphocytes. I. Preferable activation of CD4+ T cells in a responder strain. J. Immunol. 154 (1995) 3138-3146
30. Jordan M.A. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr. Med. Chem. Anti-Cancer Agents 2 (2002) 1-17
31. Kastrup J., Lauritsen J.P., Menne C., Dietrich J., and Geisler C. The phosphatase domains of CD45 are required for ligand induced T-cell receptor downregulation. Scand. J. Immunol. 51 (2000) 491-496
32. Kauppinen R.A., Komulainen H., and Taipale H. Cellular mechanisms underlying the increase in cytosolic free calcium concentration induced by methylmercury in cerebrocortical synaptosomes from guinea pig. J. Pharmacol. Exp. Ther. 248 (1989) 1248-1254
33. Kim E., Kim J.H., Kim H.S., Ryu S.H., and Suh P.G. Thimerosal stimulates focal adhesion kinase and cytoskeletal changes by redox modulation. Biochim. Biophys. Acta 1593 (2002) 9-15
34. Kosuda L.L., Hannigan M.O., Bigazzi P.E., Leif J.H., and Greiner D.L. Thymus atrophy and changes in thymocyte subpopulations of BN rats with mercury-induced renal autoimmune disease. Autoimmunity 23 (1996) 77-89
35. Lauritsen J.P., Christensen M.D., Dietrich J., Kastrup J., Odum N., and Geisler C. Two distinct pathways exist for down-regulation of the TCR. J. Immunol. 161 (1998) 260-267
36. Lauritsen J.P., Menne C., Kastrup J., Dietrich J., and Geisler C. Protein phosphatase 2A isotypes regulate cell surface expression of the T cell receptor. Exp. Clin. Immunogenet. 18 (2001) 24-33
37. Liu H., Rhodes M., Wiest D.L., and Vignali D.A. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 13 (2000) 665-675
38. Maltsev V.A., Wolff B., Hess J., and Werner G. Calcium signalling in individual T-cells measured by confocal microscopy. Immunol. Lett. 42 (1994) 41-47
39. Matsuda M., Maeda Y., Shirakawa C., Morita S., Koyama A., Horiuchi F., Hamazaki H., Irimajiri K., and Horiuchi A. Possible involvement of protein kinase C activation in down-regulation of CD3 antigen on adult T cell leukaemia cells. Br. J. Haematol. 86 (1994) 399-401
40. Menne C., Moller Sorensen T., Siersma V., von Essen M., Odum N., and Geisler C. Endo- and exocytic rate constants for spontaneous and protein kinase C-activated T cell receptor cycling. Eur. J. Immunol. 32 (2002) 616-626
41. Miceli M.C., Moran M., Chung C.D., Patel V.P., Low T., and Zinnanti W. Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin. Immunol. 13 (2001) 115-128
42. Miura K., Inokawa M., and Imura N. Effects of methylmercury and some metal ions on microtubule networks in mouse glioma cells and in vitro tubulin polymerization. Toxicol. Appl. Pharm. 73 (1984) 218-231
43. Miura K., Kobayashi K., Toyoda H., and Imura N. Methylmercury-induced microtubule depolymerization leads to inhibition of tubulin synthesis. J. Toxicol. Sci. 23 (1998) 379-388
44. Miura K., Koide N., Himeno S., Nakagawa I., and Imura N. The involvement of microtubular disruption in methylmercury-induced apoptosis in neuronal and nonneuronal cell lines. Toxicol. Appl. Pharmacol. 160 (1999) 279-288
45. Mollinedo F., and Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8 (2003) 413-450
46. Monks C.R., Freiberg B.A., Kupfer H., Sciaky N., and Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395 (1998) 82-86
47. Muller S., Demotz S., Bulliard C., and Valitutti S. Kinetics and extent of protein tyrosine kinase activation in individual T cells upon antigenic stimulation. Immunology 97 (1999) 287-293
48. Nakashima I., Pu M.Y., Nishizaki A., Rosila I., Ma L., Katano Y., Ohkusu K., Rahman S.M., Isobe K., Hamaguchi M., et al. Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals. J. Immunol. 152 (1994) 1064-1071
49. Nakatsuru S., Oohashi J., Nozaki H., Nakada S., and Imura N. Effect of mercurials on lymphocyte functions in vitro. Toxicology 36 (1985) 297-305
50. O'Brien E.T., Salmon E.D., and Erickson H.P. How calcium causes microtubule depolymerization. Cell Motil. Cytoskeleton 36 (1997) 125-135
51. Pelassy C., Breittmayer J.P., Ticchioni M., and Aussel C. Effect of thimerosal on cytosolic calcium and phosphatidylserine synthesis in Jurkat T cells. Int. J. Biochem. 26 (1994) 93-96
52. Pintado E., Baquero-Leonis D., Conde M., and Sobrino F. Effect of thimerosal and other sulfhydryl reagents on calcium permeability in thymus lymphocytes. Biochem. Pharmacol. 49 (1995) 227-232
53. Rahman S.M., Pu M.Y., Hamaguchi M., Iwamoto T., Isobe K., and Nakashima I. Redox-linked ligand-independent cell surface triggering for extensive protein tyrosine phosphorylation. FEBS Lett. 317 (1993) 35-38
54. Rosenspire A.J., Bodepudi S., Mathews M., and McCabe Jr. M.J. Low levels of ionic mercury modulate protein tyrosine phosphorylation in lymphocytes. Int. J. Immunopharmacol. 20 (1998) 697-707
55. Salio M., Valitutti S., and Lanzavecchia A. Agonist-induced T cell receptor down-regulation: molecular requirements and dissociation from T cell activation. Eur. J. Immunol. 27 (1997) 1769-1773
56. Sapin C., Druet E., and Druet P. Induction of anti-glomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. Clin. Exp. Immunol. 28 (1977) 173-179
57. Sechi A.S., and Wehland J. Interplay between TCR signalling and actin cytoskeleton dynamics. Trends Immunol. 25 (2004) 257-265
58. Shenker B.J., Berthold P., Decker S., Mayro J., Rooney C., Vitale L., and Shapiro I.M. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. II. Alterations in cell viability. Immunopharmacol. Immunotoxicol. 14 (1992) 555-577
59. Shenker B.J., Berthold P., Rooney C., Vitale L., DeBolt K., and Shapiro I.M. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. III. Alterations in B-cell function and viability. Immunopharmacol. Immunotoxicol. 15 (1993) 87-112
60. Shenker B.J., Datar S., Mansfield K., and Shapiro I.M. Induction of apoptosis in human T-cells by organomercuric compounds: a flow cytometric analysis. Toxicol. Appl. Pharmacol. 143 (1997) 397-406
61. Shenker B.J., Guo T.L., and Shapiro I.M. Mercury-induced apoptosis in human lymphoid cells: evidence that the apoptotic pathway is mercurial species dependent. Environ. Res. 84 (2000) 89-99
62. Silbergeld E.K., Sacci Jr. J.B., and Azad A.F. Mercury exposure and murine response to Plasmodium yoelii infection and immunization. Immunopharmacol. Immunotoxicol. 22 (2000) 685-695
63. 2 concentrations transitorily duplicate the ATP level in Saccharomyces cerevisiae cells. FEBS Lett. 579 (2005) 4044-4048
64. Tan X.X., Tang C., Castoldi A.F., Manzo L., and Costa L.G. Effects of inorganic and organic mercury on intracellular calcium levels in rat T lymphocytes. J. Toxicol. Environ. Health 38 (1993) 159-170
65. Unal-Cevik I., Kilinc M., Can A., Gursoy-Ozdemir Y., and Dalkara T. Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia. Stroke 35 (2004) 2189-2194
66. Valitutti S., Meuller S., Salio M., and Lanzavecchia A. Degradation of T cell receptor TCR-CD3-zeta complexes after antigenic stimulation [see comments]. J. Exp. Med. 185 (1997) 1859-1864
67. Van Horn D.L., Edelhauser H.F., Prodanovich G., Eiferman R., and Pederson H.F. Effect of the ophthalmic preservative thimerosal on rabbit and human corneal endothelium. Invest. Ophthalmol. Vis. Sci. 16 (1977) 273-280
68. 2+ signals during early lymphocyte activation in carp Cyprinus carpio L. J. Exp. Biol. 201 (1998) 591-598
69. Verstraeten T., Davis R.L., DeStefano F., Lieu T.A., Rhodes P.H., Black S.B., Shinefield H., and Chen R.T. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 112 (2003) 1039-1048
70. Vojdani A., Pangborn J.B., Vojdani E., and Cooper E.L. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16 (2003) 189-199
71. Volbracht C., Leist M., and Nicotera P. ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation. Mol. Med. 5 (1999) 477-489
72. Warfvinge K., Hansson H., and Hultman P. Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice: dose-response studies. Toxicol. Appl. Pharmacol. 132 (1995) 299-309
73. Wasteneys G.O., Cadrin M., Reuhl K.R., and Brown D.L. The effects of methylmercury on the cytoskeleton of murine embryonal carcinoma cells. Cell Biol. Toxicol. 4 (1988) 41-60
74. Westphal G., and Hallier E. Mercury in infants given vaccines containing thiomersal. Lancet 361 (2003) 699 author reply 699